Selective Internal Radiotherapy (SIRT) for Hepatocellular Carcinoma

被引：10
|
作者：
Antoch, G. [1 ]
Mueller, S. P. [2 ]
Hamami, M. [2 ]
Heusner, T. A. [1 ]
Ertle, J. [3 ]
Hilgard, P. [3 ]
Forsting, M. [1 ]
Bockisch, A. [3 ]
机构：
[1] Univ Duisburg Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Univ Klin Essen, D-45127 Essen, Germany
[2] Univ Duisburg Essen, Klin Gastroenterol & Hepatol, Univ Klinikum Essen, D-45127 Essen, Germany
[3] Univ Duisburg Essen, Klin Nukl Med, Univ Klin Essen, D-45127 Essen, Germany
来源：
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 2010年 / 182卷 / 08期
关键词：
SIRT; radioembolization; embolization; interventional procedures; liver; HCC; INTRAHEPATIC YTTRIUM-90 MICROSPHERES; Y-90; MICROSPHERES; PARTITION MODEL; LIVER; RADIOEMBOLIZATION; RADIATION; BRACHYTHERAPY; MANAGEMENT;
D O I：
10.1055/s-0029-1245380
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Microsphere-based radioembolization represents a new generation of therapeutics in interventional oncology. The intrahepatic application of radioactive microspheres via the hepatic artery allows locoregional therapy of diffuse or multifocal liver tumors, for which to date systemic therapy was the only remaining option. The current standard for this selective internal radiotherapy or radioembolization is yttrium-90 glass or resin microspheres. This review discusses the indications, the technique, and the therapeutic results of microsphere-based radioembolization.
引用
收藏
页码：660 / 670
页数：11
相关论文
共 50 条
  • [31] Selective internal radiotherapy (SIRT) with 90Y-Therasphere in Hepatocellular Carcinoma (HCC) with and without portal vein thrombosis (PVT): prospective study at National Cancer Institute of Milan
    Maccauro, M.
    Seregni, E.
    Chiesa, C.
    Romito, R.
    Spreafico, C.
    Morosi, C.
    Aliberti, G.
    Lanocita, R.
    Sposito, C.
    Marchiano, A.
    Mazzaferro, V.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S278 - S279
  • [32] THE MAAPE SCORE PREDICTS SURVIVAL IN THOSE TREATED WITH YTTRIUM-90 SELECTIVE INTERNAL RADIOTHERAPY IN HEPATOCELLULAR CARCINOMA
    Wallace, Michael Christopher
    Samuelson, Shaun
    Khoo, Tiffany
    Ooi, Jacob
    Tibballs, Jonathan
    Ferguson, John
    Preen, David B.
    Knuiman, Mathew
    Garas, George
    MacQuillan, Gerry C.
    Adams, Leon A.
    Jeffrey, Gary P.
    HEPATOLOGY, 2019, 70 : 237A - 237A
  • [33] Selective internal radiation therapy (SIRT) with Yttrium-90 (90Y) radiomicrospheres in the treatment of unresectable hepatocellular carcinoma
    Arslan, N.
    Emi, M.
    Alagoz, E.
    Ustunsoz, B.
    Oysul, K.
    Beyzadeoglu, M.
    Gorgulu, S.
    Ozguven, M. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S479 - S480
  • [34] Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
    Finessi, Monica
    Cioffi, Martina
    Grimaldi, Serena
    Fronda, Marco
    Rovera, Guido
    Passera, Roberto
    Carucci, Patrizia
    Gaia, Silvia
    Rolle, Emanuela
    Rizza, Giorgia
    Colli, Fabio
    Saracco, Giorgio Maria
    Romagnoli, Renato
    Calandri, Marco
    Fonio, Paolo
    Morbelli, Silvia Daniela
    Breatta, Andrea Doriguzzi
    RADIOLOGIA MEDICA, 2025, 130 (02): : 271 - 279
  • [35] COST-COMPARISON ANALYSIS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) AND TRANSARTERIAL CHEMOEMBOLISATION (TACE) IN UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
    Muszbek, N.
    Evans, R.
    Remak, E.
    Brennan, V
    Colaone, F.
    Shergill, S.
    VALUE IN HEALTH, 2019, 22 : S455 - S455
  • [36] Selective internal radiation therapy (SIRT) promotes the recruitment of tumor-infiltrating lymphocytes and enhances cytotoxic activity in hepatocellular carcinoma
    Craciun, L.
    De Wind, R.
    Demetter, P.
    Lucidi, V.
    Michiels, S.
    Garaud, S.
    Naveaux, C.
    Galdon, M. Gomez
    Hendlisz, A.
    Gallo, K. Willard
    Flamen, P.
    Larsimont, D.
    Donckier, V.
    ANNALS OF ONCOLOGY, 2017, 28 : 3 - 3
  • [37] ALBI score affects Overall Survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
    Cioffi, M.
    Grimaldi, S.
    Fronda, M.
    Breatta, A. Doriguzzi
    Rovera, G.
    Passera, R.
    Fonio, P.
    Morbelli, S.
    Finessi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S411 - S411
  • [38] Selective Internal Radiotherapy (SIRT) in malignant liver tumors:: First clinical results.
    Palmedo, H.
    Ezziddin, S.
    Bucerius, J.
    Brockmann, H.
    Logvinski, T.
    Tuerler, A.
    Lammert, N.
    Flacke, S.
    Biersack, H.
    Wilhelm, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S137 - S137
  • [39] Assessment of the Risk of Liver Toxicity of liver SBRT after Selective internal Radiotherapy (SIRT)
    Grosser, O. S.
    Walke, M.
    Abdullayev, N.
    Andrae, K.
    Woerdehoff, H.
    Kreissl, M. C.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S102 - S102
  • [40] Radioactive Microspheres for Selective Internal Radiation Therapy of Hepatocellular Carcinoma
    Zhou, Yi
    Gao, Yun
    Duan, Guangxin
    Wen, Ling
    Shan, Shanshan
    Wu, Shuwang
    Zeng, Jianfeng
    Gao, Mingyuan
    ADVANCED NANOBIOMED RESEARCH, 2023, 3 (06):
12345